Dougherty & Co Maintains a 'Buy' on Vascular Solutions (VASC); Q2 Preview

Article Stock Quotes (1) Comments (0)

Dougherty & Co maintains a 'Buy' on Vascular Solutions (NASDAQ: VASC) price target of $15.50 (from $12.50).

Analyst, Deepak Chaulagai, said, "VASC will report Q2 FY12 results on July 24th after the close. We are modeling Q2 at $24.3M revenue (+9.1% Y/Y)/$0.13 GAAP EPS (+5.6% Y/Y), in-line with consensus estimates and within the range of management’s guidance ($24.1M to $24.5M revenue; $0.13 to $0.15 EPS)."

For an analyst ratings summary and ratings history on Vascular Solutions click here. For more ratings news on Vascular Solutions click here.

Shares of Vascular Solutions closed at $12.99 yesterday, with a 52 week range of $9.90-$13.75.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• Janney Capital Boosts PT on Gap (GPS) Post Q1
• Topeka Capital Starts Cavium Networks (CAVM) at Hold
• Topeka Capital Starts Spansion (CODE) at Buy

Create E-mail Alert Related Categories

Analyst Comments, Analyst EPS View

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?